Loading...
The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile
BACKGROUND: Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric em...
Saved in:
| Published in: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791885/ https://ncbi.nlm.nih.gov/pubmed/33413317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00678-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|